HOLX Stock Quote
Company Report
Hologic, Inc. is a leading developer, manufacturer, and supplier of innovative healthcare solutions focused on women's health worldwide. Founded in 1985 and headquartered in Marlborough, Massachusetts, the company operates through four core segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Hologic's extensive portfolio includes a wide range of products designed for early detection, diagnosis, and treatment across various medical disciplines.
In the Diagnostics segment, Hologic offers Aptima molecular diagnostic assays that detect infectious microorganisms and viral load assays for Hepatitis B virus, Hepatitis C virus, HIV, and human cytomegalovirus. The company also provides diagnostic assays for vaginitis and assays for detecting SARS-CoV-2, contributing significantly to infectious disease management globally. Additionally, Hologic's Breast Health segment delivers comprehensive solutions for breast cancer care, including digital mammography systems, 3D mammography, ultrasound imaging, biopsy guidance systems, and breast conserving surgery products.
Hologic's GYN Surgical segment offers advanced surgical products such as the NovaSure Endometrial Ablation System, MyoSure Hysteroscopic Tissue Removal System, and Fluent Fluid Management System, enhancing minimally invasive procedures for women's health conditions. In the Skeletal Health segment, the company provides innovative dual energy X-ray systems and mini C-arm devices for orthopedic surgical procedures. Through direct sales, service teams, and a network of distributors and representatives, Hologic continues to expand its global reach, striving to improve healthcare outcomes and empower clinicians with cutting-edge diagnostic and surgical technologies.
HOLX EPS Chart
HOLX Revenue Chart